Stopped early
Fluorescence Imaging + ICG Dye for Use in the Visual Diagnosis of Endometriosis
NCT02038985 · AdventHealth · Updated 6 Oct 2017
- What is being tested
- Participants will receive ICG Dye
- For
- Endometriosis
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 55 years. About 18 people. The full rules are on the registry page.
- Where
- United States
- When
- Starts or started June 2013, ends 16 Aug 2016. Registered 17 Jan 2014.
- Results
- None posted yet.
In the researchers' words
The purpose of this study is to evaluate the use of fluorescence imaging + Indocyanine Green (ICG) dye ("Firefly"), compared to standard white light imaging in 2D and 3D, for accurate visual diagnosis of endometriosis during a da Vinci robotically guided endometriosis resection procedure.
Sites
- Florida Hospital Celebration HealthCelebration, Florida, United States